Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-151932
Filing Date
2021-05-05
Accepted
2021-05-05 17:20:51
Documents
1
Group Members
BIOTECH GROWTH N.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G d846620dsc13g.htm SC 13G 61425
  Complete submission text file 0001193125-21-151932.txt   62978
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Subject) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-88939 | Film No.: 21894608
SIC: 2834 Pharmaceutical Preparations